Promente Clinical Research Center
KOASTAL-3 clinical trial
Evaluation of an investigational molecule in depression.
Study information
KOASTAL-3 is conducted by Neumora Therapeutics (NMRA-335140-303). It is a clinical trial evaluating an investigational molecule in people with depression.
Who is this study for?
The study is intended for patients diagnosed with depression who may meet protocol criteria and want to discuss participation in a controlled clinical trial with specialists.